The Cancer Survivors Network (CSN) is a peer support community for cancer patients, survivors, caregivers, families, and friends! CSN is a safe place to connect with others who share your interests and experiences.

Thank you for being a part of the Cancer Survivor Network community. Survivors and caregivers like you have played a unique role in fostering an online environment that encourages connection among those needing support, community, and education. On May 28, the Network will be discontinued. More details are available here . If you have any questions, contact CSNSupportTeam@cancer.org. Thanks again for the support you’ve provided each other over the years. We remain committed to supporting you in other ways throughout your cancer journey.

Great news for HCC Patients

MyJourneywithCancer
MyJourneywithCancer CSN Member Posts: 82
in Liver Cancer #1
FDA approved the PD-1 inhibitor, nivolumab (Opdivo) for the treatment of hepatocellular carcinoma (HCC) after disease progression despite treatment with sorafenib.

More here:
http://cancerdiscovery.aacrjournals.org/content/early/2017/10/04/2159-8290.CD-NB2017-138.long
Like Care

Comments

  • Positiveme
    Positiveme CSN Member Posts: 10
    #2
    Than you for info and never

    Than you for info and never give up. 

    I beleive advanced technology could cure this HCC one day. :)

    Like Care
  • Liver cancer
    Liver cancer CSN Member Posts: 52 Member
    edited February 2018 #3
    New life saving drugs

    Hurray. We are so lucky to be alive in this time when liver disease and specifically liver cancer is making such huge strides.

    Like Care

Discussion Boards